Vanta Bioscience Financials

BSE: 540729

₹19.64

₹-1.03 (-4.98%)

As on 13-Aug-2026IST

Market cap

₹14 Cr

Revenue (TTM)

₹2 Cr

P/E Ratio

129.3

P/B Ratio

1

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	1.96	9.72	6.28	9.69	9.82	13.75
Total Income	2.07	9.83	6.96	10.11	9.85	13.86
Total Expenditure	6.22	8.41	8.67	6.22	5.87	9.38
EBITDA	-4.26	1.31	-2.39	3.47	3.95	4.37
Depreciation	4.42	4.50	2.67	1.32	1.25	1.19
EBIT	-8.67	-3.18	-5.06	2.15	2.69	3.18
Interest	4.07	5.75	5.89	2.35	2.14	1.95
Other Income	0.11	0.11	0.69	0.42	0.03	0.11
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-12.63	-8.83	-10.26	0.23	0.59	1.34
Provision for Tax	0.66	-0.22	0.18	0.09	0.14	0.33
Profit after Tax	-13.29	-8.61	-10.44	0.13	0.45	1.01
Minority Interest	8.52	6.29	3.96	-0.05	0.00	-0.01
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-4.77	-2.32	-6.48	0.09	0.45	1.00

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	10.42	15.20	17.51	24.01	23.92	23.47
Minority Interest	-6.64	-2.23	1.41	5.34	2.31	0.99
Non-Current Liabilities	55.53	49.64	48.03	37.78	28.56	14.24
Current Liabilities	26.56	22.79	17.75	14.32	14.89	10.03
Total Liabilities	85.88	85.40	84.71	81.45	69.68	48.73

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	70.52	68.24	69.47	66.91	49.69	28.73
Current Assets	15.36	17.17	15.24	14.54	19.99	20.00
Total Assets	85.88	85.40	84.71	81.45	69.68	48.73
Total Debt*	70.08	60.95	57.16	44.87	35.97	17.37
Net Current Assets	-11.21	-5.62	-2.50	0.22	5.09	9.97
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-2.41	2.68	-0.63	5.28	6.97	2.34
Cash Flow from Investing Activities	-6.69	-3.31	-5.91	-17.18	-22.19	-7.35
Cash from Financing Activities	9.16	0.69	6.41	9.48	17.68	1.94
Net Cash Inflow / Outflow	0.06	0.06	-0.13	-2.43	2.46	-3.07

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	-7.56	-3.67	-10.27	0.14	0.71	1.59
Cash EPS (₹)	-14.06	-6.51	-12.32	2.30	2.69	3.49
Adjusted Book Value (₹)	16.51	24.08	27.75	38.03	37.89	37.18
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-3.82	4.25	-0.99	8.36	11.05	3.71
Free Cash Flow per Share (₹)	-21.91	-9.83	-56.06	3.97	6.11	-0.45

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	-10.93	-4.08	-6.10	4.00	5.42	8.62
ROE (%)	-103.74	-52.62	-50.31	0.56	1.89	4.43
ROA (%)	-15.52	-10.12	-12.57	0.18	0.76	2.31
EBIT Margin (%)	-441.66	-32.75	-80.69	22.22	27.45	23.12
Net Margin (%)	-640.68	-87.56	-150.00	1.33	4.55	7.31
Cash Profit Margin (%)	-451.95	-42.27	-123.88	14.98	16.93	15.57

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	-79.80	54.92	-35.22	-1.30	-28.63	13.85
EBIT Growth (%)	-172.37	37.13	-335.30	-20.12	-15.28	24.09
Net Profit Growth (%)	-54.42	17.60	-7,855.72	-69.96	-55.73	45.14
EPS Growth (%)	-106.18	64.26	-7,449.46	-80.38	-55.25	44.23
Book Value Growth (%)	-31.42	-13.22	-27.04	0.37	1.92	5.49

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	786.33	228.87	57.18
Price / Book Value	1.34	2.66	2.07	2.89	4.30	2.45
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-20.22	71.30	-54.70	29.29	34.22	16.66
Close Price (₹)	22.12	64.00	57.50	109.85	163.00	91.00
High Price (₹)	75.24	101.64	137.50	190.00	195.50	195.00
Low Price (₹)	21.97	37.00	55.77	105.00	80.00	80.00
Market Cap (₹ Cr)	13.96	40.40	36.29	69.34	102.89	57.44

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	6.72	4.01	3.26	1.87	1.50	0.74
Short term debt to equity ratio	0.80	0.35	0.21	0.13	0.17	0.08
Current Ratio	0.58	0.75	0.86	1.02	1.34	1.99
Quick Ratio	0.33	0.42	0.46	0.51	0.69	0.60
Interest Coverage	-2.10	-0.54	-0.74	1.10	1.28	1.69

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	127.48	32.30	31.21	11.71	20.53	10.12
Asset Turnover	0.02	0.11	0.08	0.13	0.17	0.32
Receivable days	524.58	95.72	89.94	59.32	61.93	38.14
Inventory Days	1,303.78	275.51	418.55	320.25	432.17	300.03
Payable days	1,437.15	2,480.59	1,287.00	761.36	213.02	146.72
Cash Conversion Cycle	391.21	-2,109.35	-778.52	-381.79	281.09	191.45